AstraZeneca will demolish 450,000 square feet of laboratory space in three buildings at its North American headquarters campus off Concord Pike in Fairfax as part of its global restructuring, the drug giant has confirmed.
AstraZeneca spokesman Tony Jewell said the company considered "many, many options" for the buildings but determined that it "would not be cost-effective for us to lease or repurpose the buildings for a variety of reasons." Jewell would not be more specific about options the company considered.
Jewell said AstraZeneca employees have been notified of the demolition plans, and site work will not be complete there until 2013. The company has not determined what it will do with the open space, but demolition will begin sometime later this year.
No comments:
Post a Comment